Fetzima (Levomilnacipran) is a serotonin-norepinephrine reuptake inhibitor that was approved by the FDA in 2013 to treat major depression. It is similar to the older drug milnacipran, but contains the “levo”-stereoisomer – making it slightly different. This antidepressant is regarded as being significantly different from other SNRIs in that it inhibits norepinephrine reuptake to a greater …
Brintellix (Vortioxetine) is a drug that was approved by the FDA in 2013 to treat major depression. It is regarded as an atypical antidepressant, meaning that it’s mechanisms of action are unique from other classifications. As the marketing and promotion of this newer (2013) antidepressant continues, the number of people experimenting with it for their …
Caffeine is the most universally consumed stimulant of the central nervous system. It works primarily as an adenosine antagonist. Adenosine itself works as an inhibitory neurotransmitter that helps suppress activity in the central nervous system. Since caffeine is an antagonist for the adenosine receptors, it tends to speed up nervous system activity in a dose-related …